Idera completes direct public offering

Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Business: Cancer, Infectious, Autoimmune Date completed: 8/3/10 Type: Direct public offering Raised: $15.1 million Units: 4.1 million Price: ...